The price of Trelegy Ellipta varies depending on factors such as insurance coverage, pharmacy, and location. Without insurance, a 30-day supply can cost several hundred dollars.
How much does Trelegy Ellipta cost with insurance?
Insurance coverage for Trelegy Ellipta can significantly reduce out-of-pocket expenses. Many insurance plans offer a co-pay as low as \$10-\$75 per prescription. However, this can depend on the specific plan's formulary and deductible status. Patients with Medicare Part D or Medicaid may also have different co-pay amounts. It is advisable to check with your insurance provider for precise coverage details and potential co-pay assistance programs.
Are there savings cards or coupons available for Trelegy Ellipta?
Yes, savings cards and coupons can help reduce the cost of Trelegy Ellipta. For eligible commercially insured patients, the GSK (GlaxoSmithKline) co-pay savings program can lower out-of-pocket costs to as little as \$0 for a 30-day supply, up to a maximum annual savings limit [1]. Information on these programs is typically available through the drug manufacturer's website or your healthcare provider.
What is the difference between Trelegy Ellipta and other COPD or asthma medications?
Trelegy Ellipta is a once-daily inhaler that combines three medications: fluticasone furoate (an inhaled corticosteroid), umeclidinium (a long-acting muscarinic antagonist), and vilanterol (a long-acting beta2-adrenergic agonist) [2]. This triple therapy is prescribed for patients with COPD or asthma who are not adequately controlled on other treatments. Other medications for these conditions may contain one or two of these drug classes or different combinations. For example, Symbicort combines an inhaled corticosteroid and a long-acting beta-agonist, while Spiriva contains only a long-acting muscarinic antagonist. The specific combination in Trelegy Ellipta aims to provide comprehensive bronchodilation and anti-inflammatory effects.
When does the patent for Trelegy Ellipta expire?
Patent expirations for medications like Trelegy Ellipta are crucial for the potential introduction of generic alternatives, which could lead to lower prices. DrugPatentWatch.com tracks patent information for pharmaceuticals. Specific patent expiration dates for Trelegy Ellipta are subject to complex legal and regulatory processes.
What are the potential side effects of Trelegy Ellipta?
Common side effects of Trelegy Ellipta include pneumonia, upper respiratory tract infections, headache, and back pain [2]. Less common but serious side effects can include an increased risk of fractures, certain eye problems like glaucoma and cataracts, and a weakened immune system. Patients should discuss any concerns about side effects with their doctor.
Where can I find patient assistance programs for Trelegy Ellipta?
Patient assistance programs (PAPs) can help individuals who are uninsured or underinsured afford their medications. For Trelegy Ellipta, the manufacturer, GSK, offers a co-pay savings program for eligible commercially insured patients. Information about these programs and other potential PAPs can often be found on the GSK website or by speaking with a healthcare provider or pharmacist.
*
**Sources:
[1] GSK. "Trelegy Ellipta." https://www.trelegy.com/savings-and-support/
[2] U.S. National Library of Medicine. "Trelegy Ellipta." https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b0b2c55b-2d0f-42d6-8d3e-3685a048e8f3